Published on : Jul 21, 2017
Albany, New York, July 21, 2017: Market Research Hub (MRH) has freshly broadcasted a study titled “Masimo Corp (MASI)-Product Pipeline Analysis, 2017 Update” to its vast archive of research reports. This study provides company insights along with its pipeline analysis on all pipeline products of the company. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
In the first part, the report briefly highlights Masimo Corp Company snapshot together with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. Through this report, buyers will get a detailed understanding of consumption to align their sales and marketing efforts with the latest trends in the market. Also, they can identify the areas of growth and opportunities, which will aid effective marketing planning.
Masimo Corp (Masimo), incorporated on May 7, 1996 is a global medical technology company. It manufactures and issues non-invasive patient monitoring technologies such as medical devices and a wide range of sensors to improve patient care. The company’s crucial products include pulse oximeters, patient monitors, specialty sensors, remote alarm, central monitoring systems, circuit boards and monitoring solutions. Today, Masimo is publicly traded and employs over 4,000 people worldwide, with annual revenues of around $700 million.
It has been analyzed that Signal Extraction Technology (SET) is the company's lead technology that helps to detect life-threatening actions. Also, the company has developed the Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be examined through a personal computer (PC)-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones. CO-Oximetry is another technology which allows noninvasive and continuous monitoring of blood constituents, brain and inhalation.
Moving further, the research finds that the company operates in various markets across North and South America, EMEA, Asia and Australia. Masimo is headquartered in Irvine, California, the U.S. The products offered by the company is marketed directly and through distributors and original equipment manufacturers to hospitals, long-term care facilities, emergency medical services physician offices, veterinarians and consumers market. Further, each pipeline product is profiled to cover information on product description, function and technology. The report include following products, such as Adaptive Threshold Alarm, ANI MOC-9 Module – Root, Masimo rainbow SET - Oxygen Reserve Index Clinical Trial, Eve Newborn Screening Application For Radical-7 Pulse CO-Oximeter, Halo Index, Rad-67 Rainbow Pulse CO-Oximeter, iSpO2 Rx - Professional Version, Masimo rainbow SET - SpfO2, Root Iris Display App, Next Generation SedLine and others.
Some of the latest developments announced in June 2017 by the company includes market release of Rad-67 rainbow Pulse CO-Oximeter with Next Generation. Additionally, Masimo and Mdoloris announce Masimo Open Connect Partnership for the Root Patient Monitoring and Connectivity Hub.
Click here to get more info with TOC in a PDF Format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1222537
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com